Osteopatijos namai - Company finances
|
EUR
|
2020
From: 2020-06-26
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 7,065 | 35,820 | 38,890 | 48,215 | 118,886 | 179,593 |
| Profit before tax | 1,862 | -4,849 | -1,933 | -6,602 | 40,283 | 59,015 |
| Net profit | 1,862 | -4,849 | -1,933 | -6,602 | 38,940 | 55,470 |
| Equity | 2,862 | -1,987 | -3,920 | -10,522 | 28,418 | 80,374 |
| Liabilities | - | - | 8,372 | 16,018 | 51,152 | 51,541 |
| Non-current assets | 0 | 0 | 0 | 0 | 59,704 | 48,509 |
| Current assets | 3,507 | 3,851 | 4,452 | 5,496 | 19,866 | 83,406 |
| Total assets | 3,507 | 3,851 | 4,452 | 5,496 | 79,570 | 131,915 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 8,128 | 23,558 | 34,752 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +407.0% | +8.6% | +24.0% | +146.6% | +51.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 53.1% | -125.9% | -43.4% | -120.1% | 48.9% | 42.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 65.1% | - | - | - | 137.0% | 69.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 26.4% | -13.5% | -5.0% | -13.7% | 32.8% | 30.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 26.4% | -13.5% | -5.0% | -13.7% | 33.9% | 32.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 1.8 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Osteopatijos namai - Social security debts
The company had no debts to Sodra
Osteopatijos namai - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Osteopatijos namai, MB (company code 305580695) is a Lithuanian small partnership engaged in medical specialists activities. In 2025, the company generated revenue of EUR 179.6K and net profit of EUR 55.5K, corresponding to a profit margin of 30.9%. Revenue increased by 51.1% year on year, while profit remained strong after a profitable 2024. The three-year trajectory shows a clear expansion: revenue rose from EUR 48.2K in 2023 to EUR 118.9K in 2024 and EUR 179.6K in 2025, while net profit moved from a loss of EUR 6.6K in 2023 to EUR 38.9K in 2024 and EUR 55.5K in 2025. Balance sheet strength also improved over the period. At the end of 2025, total assets were EUR 131.9K, equity EUR 80.4K and liabilities EUR 51.5K. The equity ratio was 60.9%, debt-to-equity 0.64, ROE 69.0%, ROA 42.0% and asset turnover 1.36x. Long-term assets stood at EUR 48.5K and short-term assets at EUR 83.4K.